#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3587233	B	Inhibition of human recombinant PDE4D3 expressed in baculoviral system using cAMP as substrate at 10 uM by fluorescence polarization assay relative to control	Homo sapiens	9		assay format	Scientific Literature
2.	ALA3587234	B	Inhibition of human recombinant PDE4D3 expressed in baculoviral system using cAMP as substrate by fluorescence polarization assay	Homo sapiens	9		assay format	Scientific Literature
3.	ALA3587235	B	Inhibition of human recombinant PDE4A4 expressed in baculoviral system using cAMP as substrate at 10 uM by fluorescence polarization assay relative to control	Homo sapiens	10		assay format	Scientific Literature
4.	ALA3587236	B	Inhibition of human recombinant PDE4B2 expressed in baculoviral system using cAMP as substrate at 10 uM by fluorescence polarization assay relative to control	Homo sapiens	10		assay format	Scientific Literature
5.	ALA3587237	B	Inhibition of human recombinant PDE4C2 expressed in baculoviral system using cAMP as substrate at 10 uM by fluorescence polarization assay relative to control	Homo sapiens	10		assay format	Scientific Literature
6.	ALA3587238	A	Cytotoxicity against human HTLA-230 cells at 100 uM after 24 hrs by lactate dehydrogenase release assay (Rvb = 0.67 +/- 0.24%)	Homo sapiens	9		cell-based format	Scientific Literature
7.	ALA3587240	T	Genotoxicity in human HTLA-230 cells assessed as gamma-H2AX production at 100 uM after 24 hrs by Western blot analysis	Homo sapiens	5		cell-based format	Scientific Literature
8.	ALA3587241	B	Inhibition of PDE4D in human HTLA-230 cells assessed as increase in forskolin-induced cAMP accumulation at 100 uM pretreated for 10 mins followed by forskolin induction measured after 20 mins by enzyme immunoassay	Homo sapiens	2		cell-based format	Scientific Literature
9.	ALA3587242	A	Effect on cAMP level in human HTLA-230 cells at 100 uM after 10 mins by enzyme immunoassay	Homo sapiens	2		cell-based format	Scientific Literature
10.	ALA3587243	T	Toxicity in mouse assessed as sedative effect by measuring reduction of total distance traveled at 10 mg/kg, po measured over 60 mins by open-field test	Mus musculus	6		organism-based format	Scientific Literature
11.	ALA3587244	T	Toxicity in mouse assessed as sedative effect by measuring prolongation of immobility time at 10 mg/kg, po measured over 60 mins by open-field test	Mus musculus	6		organism-based format	Scientific Literature
12.	ALA3587245	A	Tmax in BALB/c mouse plasma at 10 mg/kg, sc by LC-MS/MS analysis	Mus musculus	2		organism-based format	Scientific Literature
13.	ALA3587246	A	Cmax in BALB/c mouse plasma at 10 mg/kg, sc by LC-MS/MS analysis	Mus musculus	2		organism-based format	Scientific Literature
14.	ALA3587247	A	Elimination half life in BALB/c mouse plasma at 10 mg/kg, sc by LC-MS/MS analysis	Mus musculus	2		organism-based format	Scientific Literature
15.	ALA3587248	A	AUC (0 to t) in BALB/c mouse plasma at 10 mg/kg, sc by LC-MS/MS analysis	Mus musculus	2		organism-based format	Scientific Literature
16.	ALA3587249	A	Tmax in BALB/c mouse brain at 10 mg/kg, sc by LC-MS/MS analysis	Mus musculus	2		organism-based format	Scientific Literature
17.	ALA3587250	A	Cmax in BALB/c mouse brain at 10 mg/kg, sc by LC-MS/MS analysis	Mus musculus	2		organism-based format	Scientific Literature
18.	ALA3587251	A	Elimination half life in BALB/c mouse brain at 10 mg/kg, sc by LC-MS/MS analysis	Mus musculus	2		organism-based format	Scientific Literature
19.	ALA3587252	A	AUC (0 to t) in BALB/c mouse brain at 10 mg/kg, sc by LC-MS/MS analysis	Mus musculus	2		organism-based format	Scientific Literature
20.	ALA3587253	A	Ratio of AUC (0 to t) in BALB/c mouse brain to AUC (0 to t) in BALB/c mouse plasma at 10 mg/kg, sc by LC-MS/MS analysis	Mus musculus	2		organism-based format	Scientific Literature